Adjunctive Cilostazol Versus Double-Dose Clopidogrel After Drug-Eluting Stent Implantation
نویسندگان
چکیده
Kyung Woo Park, MD, PHD,* Si-Hyuck Kang, MD,* Jin Joo Park, MD,* Han-Mo Yang, MD, PHD,* Hyun-Jae Kang, MD, PHD,* Bon-Kwon Koo, MD, PHD,* Byoung-Eun Park, MD, PHD,y Kwang Soo Cha, MD, PHD,z Jay Young Rhew, MD, PHD,x Hui-Kyoung Jeon, MD, PHD,k Eun Seok Shin, MD, PHD,{ Ju Hyeon Oh, MD, PHD,# Myung-Ho Jeong,MD,PHD,** SanghyunKim,MD,PHD,yyKyung-KukHwang,MD,PHD,zz Jung-Han Yoon, MD, PHD,xx Sung Yun Lee, MD, PHD,kk Tae-Ho Park, MD, PHD,{{ KeonWoong Moon, MD, PHD,## Hyuck-Moon Kwon, MD, PHD,*** In-Ho Chae, MD, PHD,yyy Hyo-Soo Kim, MD, PHD*
منابع مشابه
Enhanced platelet inhibition by adjunctive cilostazol to dual antiplatelet therapy after drug-eluting stent implantation for complex lesions.
Dear Sirs, Because of the reduced neointimal hyperplasia after implantation of drug-eluting stents (DES), physicians have extended the use of DES to anatomical features beyond the approved indications (1). Stent deployment for complex lesions can increase the risk of early ischaemic events (may be due to mechanical factor and platelet activation) (2, 3). In addition, DES components can exaggera...
متن کاملThe Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation
BACKGROUND AND OBJECTIVES Placement of drug-eluting stents (DES) can be complicated by stent thrombosis; prophylactic antiplatelet therapy has been used to prevent such events. We evaluated the efficacy of cilostazol with regard to stent thrombosis as adjunctive antiplatelet therapy. SUBJECTS AND METHODS A total of 1,315 patients (846 males, 469 females) were prospectively enrolled and analyz...
متن کاملEffects of Cilostazol on the Drug-Eluting Stent in Native Coronary Arteries
Background and Objectives:Cilostazol is an antiplatelet drug with antiproliferative properties when administered after coronary bare metal stent implantation. However, its effect on clinical and angiographic outcomes after sirolimus-eluting stent (SES) implantation in native coronary arteries has not been established. Subjects and Methods:Two hundred patients who had undergone successful SES im...
متن کاملComparison of dual versus triple antiplatelet therapy after drug-eluting stent according to stent length (from the pooled analysis of DECLARE trials).
There are no practical criteria for the use of triple antiplatelet therapy after drug-eluting stent (DES) implantation. In our present report, pooled analysis of 3 randomized studies in patients with diabetes mellitus (Drug-Eluting Stenting Followed by Cilostazol treatment reduces LAte Restenosis in patients with diabetes mellitus trial) and long coronary narrowings (Drug-Eluting Stenting Follo...
متن کاملTriple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry).
BACKGROUND Cilostazol has reduced restenosis and repeat intervention after drug-eluting stent (DES) implantation. However, there is little data regarding impact of cilostazol on cardiac events after DES implantation. Therefore, we assessed the long-term efficacy and safety of cilostazol in patients undergoing successful DES implantation. METHODS The patients (n = 3,099) undergoing successful ...
متن کامل